icon-email icon-email STAY INFORMED

Join Our Mailing List

Sign up to receive news and industry updates from SUNRx.

Star Star PARTNERS IN 340B

Endorsed by State Hospital Associations

Our partnership agreements require us to go through a diligent review process, which includes evaluation of our technology solution and services. The review process also includes the following:

icon-building icon-building

Compliance Adherence

Evaluate our ability to demonstrate our business philosophy towards compliance adherence.

Management

Review our ability to successfully manage the Covered Entity, patient and pharmacy partner relationship.

Customer Care

340B Support

These associations support our 340B program and work with SUNRx to broaden program offerings for hospitals, patients, and health centers.

SUNRx
BROADEN PROGRAM OFFERINGS
Exclusive Business Partners

SUNRx is a corporate partner of 340B Health and is currently endorsed by state hospital associations as the exclusive 340B administrator of choice for their members.

Star Star PARTNERS IN 340B

Endorsed by State Hospital Associations

Our partnership agreements require us to go through a diligent review process, which includes evaluation of our technology solution and services. The review process also includes the following:

icon-building icon-building

Compliance Adherence

Evaluate our ability to demonstrate our business philosophy towards compliance adherence.

Management

Review our ability to successfully manage the Covered Entity, patient and pharmacy partner relationship.

Customer Care

340B Support

These associations support our 340B program and work with SUNRx to broaden program offerings for hospitals, patients, and health centers.

Learn more about our complete 340B solution. Ready for a change?

The 340B Drug Pricing Program was created in 1992 by the federal government and requires drug manufacturers to provide significant discounts for outpatient drugs to eligible healthcare organizations, also known as “Covered Entities.” The program is designed to provide financial benefits to Covered Entities that serve low-income and uninsured patients, enabling expansion of healthcare services to better serve their communities and to improve access to more affordable medications for their low-income and uninsured patients.

Get more info at the Health Resources & Services Administration Website

LEARN MORE AT HRSA.GOV

Apexus

Apexus is the nation's leader in creating reliable health care solutions by enhancing access to medications and improving patient care. Apexus achieves these outcomes through innovative ambulatory pharmacy solutions and support of compliant 340B programs.

Gain valuable information through 340B Prime Vendor Program (PVP) managed by Apexus™ which provides 340B education and supports program integrity through technical assistance.

Access valuable 340B educational resources through 340B PVP managed by Apexus™

GET EDUCATED AT 340BPVP.COM

GET ANSWERS AT 340BPVP.COM

340B Health

340B Health is a nonprofit membership organization of more than 1,400 public and private non-profit hospitals and health systems throughout the U.S. that participate in the 340B drug pricing program. They are the leading advocate and resource for those hospitals who serve their communities through participation in 340B.

SUNRx is a proud corporate partner of 340B Health.

Stay informed about 340B advocacy and learn more about 340B Health

LEARN MORE AT 340BHEALTH.ORG

SUNRx
EXPAND HEALTHCARE
340B Resources

The 340B Program mission is to support Covered Entities in stretching scarce federal resources to expand access to more eligible patients and in providing more comprehensive services.

If you are a pharmacy interested in working with SUNRx to participate in 340B, please contact us for more information on how to get started.

SIMPLIFIED INVENTORY

Virtual Inventory System

The Virtual Inventory System is an automated system that manages the flow of inventory, information and payments between Covered Entities, pharmacies and wholesalers. It is HIPAA & HITECH compliant. 

icon-building icon-building

Compliance

Maintains compliance against “diversion” and “Medicaid duplicate discounts”

Inventory Control

Allows contract pharmacies to dispense their own stock without the need to keep a separate 340B inventory.

Efficiency

Automates reporting and auditing requirements and reduces paperwork.

3 Ways to Optimize Your 340B Program

Submitted by cgreen@sunrx.com on Thu, 04/01/2021 - 12:03
Optimize your 340B Program Blog

The 340B program is designed to allow eligible Covered Entities to stretch scarce health care dollars to provide services to the communities they serve and support the uninsured and underinsured patients with options that help them afford their prescription medications.

Review Prescriptions and Capture Rate

Most participating Covered Entities might not be taking full advantage of the 340B program. A quick review of the total annual prescriptions written by providers compared to the total prescriptions captured in your 340B program can give you an idea of how well your program is optimized. This can be done by routinely reviewing key reports from your e-prescribe program and should always be done in collaboration with your 340B TPA to ensure that capture logic is taken into consideration. 

Close attention to the pharmacies in your network and the capture model used can provide valuable insight when evaluating your program. Certain chain pharmacies subscribe to the “all claims” capture model, which may increase your overall capture rate but can harm the profitability of your program. It may be beneficial to review the chain pharmacies in your network that subscribe to the “all claims” capture model separately as this can determine their value vs. chain pharmacies using other models, like “brand only” and “profit only.” When reviewing your annual capture rate, pay attention to all pharmacies where prescriptions are being filled by reviewing e-prescribe data and contract pharmacy performance. Patients can change the pharmacies where they go to fill their prescriptions over time. This review can identify additional pharmacies that should be contracted and added to your network.

Tap into Specialty Pharmacy

It's common to overlook capturing prescriptions written by specialists where your providers have referred patients for specialized attention. These referral providers are usually endocrinologists, dermatologists, rheumatologists, gastroenterologists, and others who treat specific disease states.

Since the prescriptions written by these referral providers can typically be higher-cost specialty medications, capturing these in your 340B program can add significant additional savings. Your policies and procedures should indicate that your providers are to document all referrals in the patient’s EMR record and ideally, all specialists should be sending a follow-up letter back to the referring provider. From this data and via detailed reports, you can identify which specialty pharmacies your patients are using to fill these prescriptions. Once identified, you can contract with each specialty pharmacy to be included in your 340B network.

A key part of capturing these referral prescriptions is to understand how your TPA’s technology works. Additional logic and functionality are required to bring these referral prescriptions into the technology. Most specialty pharmacies don’t use switch data but rather have a direct data feed to TPAs. Thus, more than a data pull from the specialty pharmacies needs to be done to effectively capture all the appropriate specialty claims. TPAs that capture specialty claims effectively have sophisticated referral claims technology, plus additional services that monitor capture logic, as these may need to be adjusted from time to time. It may be beneficial to allocate resources, additional TPA services, or an experienced 340B consultant to monitor referral capture — it can pay dividends for growing your 340B program.

SUNRx
EXTEND BENEFITS
Making Medication More Affordable

Making the medications more affordable can help to improve patient compliance and outcomes and can help hospitals to reduce their hospital readmission rates and avoid penalties.

Leverage 340B to Service the Uninsured and Underinsured

There is significant potential in building 340B programs to support uninsured and underinsured patients. Covered Entities have patients who may impact their charity care and can strain services and resources and adding an effective uninsured program can help lower the impact.

While the mission of each Covered Entity is to care for all these patients, there are specific strategies that can provide a positive impact for both the Covered Entity and its patients. Your 340B program should be fully leveraged to provide affordable medications for your uninsured and underinsured patients and to help effectively manage your charity care budget.

An effective uninsured program should have a customized sliding scale designed to meet the needs of your uninsured patients, maximize your charity care budget and have policies and procedures written and updated regularly to help your underinsured patients in times of need. A good sliding scale program will allow the Covered Entity to design a prescription plan supporting their uninsured patient population based on their ability to pay using federal poverty levels as guidelines, ability to add co-pay amounts, and more. Any uninsured patient program should include access to the lowest price prescriptions in the market (which may not always be 340B pricing). This allows each Covered Entity to stretch any subsidy amount as far as possible.

Education is also an essential part of your uninsured program to help train the medical and ancillary staff, patients, and local pharmacies on how to effectively utilize this program to improve access to more affordable medications and patient care. This education not only ensures patients receive their medications but can also improve overall patient care. Partnering with local pharmacies to assist in helping the uninsured may improve patient care and can strengthen the community.

While the 340B program can help Covered Entities stretch scarce healthcare dollars to provide services to the communities they serve, it also provides the resources to help the most vulnerable to relieve some of the burdens to the healthcare system. Optimizing your 340B program to deliver the savings to the Covered Entity is where most see value — taking care of their most vulnerable, uninsured, and underinsured patients is equally important.

 

The content in this blog is for informational purposes only and is not intended to be used in place of regulatory guidance. The opinions and views expressed herein are those of the authors and do not necessarily reflect the official position or opinions of SUNRx or any regulatory authority. Furthermore, some content may contain copyrighted material, the use of which has not always been specifically authorized by the copyright owner, but which we believe constitutes a "fair use" of any such copyrighted material as provided for in Section 107 of the US Copyright Law. We are making the information herein available in our efforts to advance understanding of the 340B program and its offerings. These views are always subject to change, revision, and rethinking at any time and may not be held in perpetuity.

By Cary Green

Referral Claims Capture

Submitted by admin on Sun, 05/30/2021 - 07:02
Referral Claims Capture Blog

Claims Capture

What is a referral prescription or claim?

Often, primary care providers will refer a patient to another provider for a second opinion or treatment diagnosis or condition that requires advanced or specialized care. Most patient referrals are to specialty providers such as endocrinology, infectious diseases, rheumatology, dermatology, etc. – and which are not directly employed by the 340B covered entity but the covered entity has established an arrangement with. These patients continue to remain under the care of their primary care provider at the covered entity. The referring provider usually makes the arrangements for their patient to be seen by the specialty provider (e.g., make the appointment) but the specialty provider may or may not always provide any notes back to the referring provider. It is best practice for these referral specialty providers to send a note or letter back to the patient’s primary care provider, summarizing their diagnosis and treatment plan and any medications they have prescribed. Any prescription medication prescribed by the specialty provider is called a referral claim.

Why can a Covered Entity capture referral prescriptions?

Patients served by a 340B covered entity where their health records are maintained and where the referral originated and the 340B covered entity maintains the responsibility for the patient’s care can be considered for 340B drug savings. The covered entity’s providers must document the patient referral in their electronic medical records (EMR) and their 340B policies and procedures must include the process where these referral prescriptions are eligible and can be captured. The 340B covered entity is obligated to show that they are responsible for the patient’s ongoing care. Each 340B covered entity should consider having official policies around provider documentation around patient referrals.

Why should a Covered Entity consider capturing referral prescriptions?

Given the current 340B environment, it is critical for 340B covered entities to identify every potential 340B prescription to render savings back to their organization. Many smaller covered entity types are foregoing savings from referral providers because they may not be aware of how to capture these claims, have the proper 340B policies & procedures in place, they do not have a way to operationalize, or they do not have the resources to execute the process. The organizations that would be ideal to implement a referral process would be Federally Qualified Health Centers and rural, safety-net hospitals. Whether building an in-house process, partnering with your TPA or engaging a consultant, it is critical for each covered entity to compliantly capture prescriptions that render savings to help them to expand services for their communities they serve.

What does the Covered Entity need to do to be able to capture referral claims?

The covered entity needs to demonstrate that they maintain the care of the patient even when the patient is referred out of the covered entity’s four walls. The covered entity’s electronic medical record (EMR) system contains much of the needed data to document care. Common elements that support responsibility of care in a referral situation are:

  • Eligible encounter at the 340B covered entity
    • Patient seen by a qualified provider at an eligible location of the 340B covered entity
  • Documentation of the outgoing referral
    • Copy of referral form including reason for the referral to an outside provider
  • Referral summary maintained by the covered entity
    • When a patient has a referral visit to an outside provider, the referral visit summary should be sent back to the 340B covered entity and logged in the patient’s medical record
  • Policies and procedures to identify 340B eligibility
    • Definition of a referral prescription
    • Process for identifying and capturing referral claims either manually or through an automated service

What is the process to capture referral claims?

The process of identifying and capturing referral claims can be tedious. Each 340B covered entity might use a unique process in terms of how they operationalize referral relationships, documentation and validate claims. Some 340B covered entities have a very manual process that utilizes their staff to review the claims per their policies and procedures and compare documentation in the EMR. Other covered entities rely on the settings that they have put in force in their 340B Third-Party Administrator logic and others employ a consultant or additional software platform to process referral claims. Ideally, the process to identify the referral claims and validate for 340B patient eligibility should be easy to review, reject, or approve with documentation for these claims within the 340B covered entity’s capture system. Just like other 340B eligible claims, referral claims must have eligibility verified using an approved provider, and an eligible patient. Once the 340B covered entity validates and approves the referral claim from a patient definition perspective, the 340B TPA will validate that other claim criteria has been met, captures the claim and returns the savings to the covered entity. No matter which process the 340B covered entity uses - manual, their TPA's system or a consultant - the capture of referral claims needs to be clearly stated in the 340B covered entity’s policies and procedures.

Referral Claims can be complex and that is why it is important to set up your program correctly and compliantly to capture 340B referral claims that may render much-needed savings back to your organization.

Have questions or need help? Contact us or learn more about Referral Capture.

 

The content in this blog is for informational purposes only and is not intended to be used in place of regulatory guidance. The opinions and views expressed herein are those of the authors and do not necessarily reflect the official position or opinions of SUNRx or any regulatory authority. Furthermore, some content may contain copyrighted material, the use of which has not always been specifically authorized by the copyright owner, but which we believe constitutes a "fair use" of any such copyrighted material as provided for in Section 107 of the US Copyright Law. We are making the information herein available in our efforts to advance understanding of the 340B program and its offerings. These views are always subject to change, revision, and rethinking at any time and may not be held in perpetuity.

Given the current 340B environment, it is critical for 340B covered entities to identify every potential 340B prescription to render savings back to their organization.

By Cary Green and Donna Petty